QNCX — Quince Therapeutics Inc · catalysts, narrative & risks

Important context: the ticker you asked about has already changed

As of the reference date (2026-10-31), Quince Therapeutics is no longer trading as QNCX. Per a Globe Newswire press release, Quince changed its name to IRulya Therapeutics Inc. effective October 9, 2026, and its common stock began trading on the Nasdaq Capital Market under the new ticker "IRLA" effective October 12, 2026 [1]. The name change followed the completion of Quince's stock-for-stock merger with privately held Orphai Therapeutics [1], [9].